Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis

Author: Kotyla Przemyslaw   Sliwinska-Kotyla Bogna   Kucharz Eugene  

Publisher: Springer Publishing Company

ISSN: 0770-3198

Source: Clinical Rheumatology, Vol.26, Iss.9, 2007-09, pp. : 1595-1596

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content